NRX Pharmaceuticals (NRXP)

NRX Pharmaceuticals (NRXP) Stock Price & Analysis


NRXP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.49 - $1.54
Previous Close$0.53
Average Volume (3M)253.23K
Market Cap
Enterprise Value$29.36M
Total Cash (Recent Filing)$16.51M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.9
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.56
Shares Outstanding70,309,655
10 Day Avg. Volume873,536
30 Day Avg. Volume253,232
Standard Deviation0.31
Financial Highlights & Ratios
Price to Book (P/B)-1.24
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.83
Price Target Upside528.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was NRX Pharmaceuticals’s price range in the past 12 months?
NRX Pharmaceuticals lowest stock price was $0.49 and its highest was $1.54 in the past 12 months.
    What is NRX Pharmaceuticals’s market cap?
    Currently, no data Available
    When is NRX Pharmaceuticals’s upcoming earnings report date?
    NRX Pharmaceuticals’s upcoming earnings report date is Aug 14, 2023 which is in 68 days.
      How were NRX Pharmaceuticals’s earnings last quarter?
      NRX Pharmaceuticals released its earnings results on May 16, 2023. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.135 by -$0.025.
        Is NRX Pharmaceuticals overvalued?
        According to Wall Street analysts NRX Pharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does NRX Pharmaceuticals pay dividends?
          NRX Pharmaceuticals does not currently pay dividends.
          What is NRX Pharmaceuticals’s EPS estimate?
          NRX Pharmaceuticals’s EPS estimate is -$0.13.
            How many shares outstanding does NRX Pharmaceuticals have?
            NRX Pharmaceuticals has 70,309,654 shares outstanding.
              What happened to NRX Pharmaceuticals’s price movement after its last earnings report?
              NRX Pharmaceuticals reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.135. Following the earnings report the stock price went down -8.571%.
                Which hedge fund is a major shareholder of NRX Pharmaceuticals?
                Among the largest hedge funds holding NRX Pharmaceuticals’s share is Owl Creek Asset Management, L.P.. It holds NRX Pharmaceuticals’s shares valued at N/A.


                  NRX Pharmaceuticals Stock Smart Score

                  The NRX Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  NRX Pharmaceuticals

                  Big Rock Partners Acquisition Corp. is a blank check company, which was formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses or entities. It focuses on identifying a prospective target business in the senior housing and care industry in the United States. The firm's care segments are commonly divided into four categories: Independent Living; Assisted Living; Memory Care and Nursing Care. The company was founded on September 18, 2017 and is headquartered in Delray Beach, FL.


                  Top 5 ETFs holding NRXP

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold NRXP. The ETFs are listed according to market value of NRXP within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Crinetics Pharmaceuticals
                  Fate Therapeutics
                  Iovance Biotherapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis